Hong Kong-listed innovative drug stocks fluctuated and strengthened, with Zai Lab (09688.HK) rising more than 5%, BeiGene (06160.HK) rising more than 4%, and WuXi AppTec (02359.HK) and Fosun Pharma (02196.HK) following suit.

2026-08-11

Hong Kong-listed innovative drug stocks fluctuated and strengthened, with Zai Lab (09688.HK) rising more than 5%, BeiGene (06160.HK) rising more than 4%, and WuXi AppTec (02359.HK) and Fosun Pharma (02196.HK) following suit.